Ghana targets first locally manufactured vaccine by 2027
Ghana is expected to produce its first locally manufactured vaccine by 2027, with production processes currently underway at Atlantic Lifesciences Limited.
Ghana aims to produce its first locally manufactured tetanus-diphtheria vaccine by 2027, with the project currently underway at Atlantic Lifesciences Limited. Chief Executive Officer of the National Vaccine Institute (NVI), Dr Sodzi Sodzi-Tettey, revealed that this initiative is progressing through a partnership involving local scientific institutions, private manufacturers, and an Indonesian pharmaceutical company.
The project aims to strengthen Ghana's domestic vaccine manufacturing capacity and reduce reliance on imported vaccines.
Brief written by urgent.news from Adom Online's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
